Millennium Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-797,100
| Closed | -$12.5M | – | 6725 |
|
|
2024
Q1 | $12.5M | Buy |
797,100
+144,846
| +22% | +$2.23M | 0.01% | 1984 |
|
|
2023
Q4 | $10.5M | Buy |
652,254
+298,064
| +84% | +$3.8M | ﹤0.01% | 2136 |
|
|
2023
Q3 | $4.51M | Buy |
354,190
+106,253
| +43% | +$1.47M | ﹤0.01% | 2797 |
|
|
2023
Q2 | $3.49M | Buy |
247,937
+171,572
| +225% | +$2.45M | ﹤0.01% | 2989 |
|
|
2023
Q1 | $1.18M | Sell |
76,365
-402,001
| -84% | -$6.71M | ﹤0.01% | 3936 |
|
|
2022
Q4 | $7.84M | Sell |
478,366
-472,953
| -50% | -$7.69M | ﹤0.01% | 2387 |
|
|
2022
Q3 | $17.6M | Buy |
951,319
+318,383
| +50% | +$5M | 0.01% | 1477 |
|
|
2022
Q2 | $8.32M | Buy |
632,936
+56,638
| +10% | +$625K | 0.01% | 2264 |
|
|
2022
Q1 | $5.34M | Sell |
576,298
-263,461
| -31% | -$2.24M | ﹤0.01% | 2854 |
|
|
2021
Q4 | $8.2M | Buy |
839,759
+500,448
| +147% | +$9.41M | ﹤0.01% | 2357 |
|
|
2021
Q3 | $11.5M | Buy |
339,311
+129,546
| +62% | +$4.13M | 0.01% | 1879 |
|
|
2021
Q2 | $7.68M | Buy |
209,765
+127,008
| +153% | +$4.92M | ﹤0.01% | 2223 |
|
|
2021
Q1 | $3.71M | Sell |
82,757
-105,090
| -56% | -$4.89M | ﹤0.01% | 2913 |
|
|
2020
Q4 | $10.7M | Buy |
187,847
+100,630
| +115% | +$5.96M | 0.01% | 1654 |
|
|
2020
Q3 | $4.47K | Buy |
87,217
+78,152
| +862% | +$3.83M | 0.01% | 1942 |
|
|
2020
Q2 | $541K | Sell |
9,065
-149,121
| -94% | -$7.98M | ﹤0.01% | 3355 |
|
|
2020
Q1 | $6.51M | Buy |
158,186
+101,992
| +181% | +$5.66M | 0.01% | 1141 |
|
|
2019
Q4 | $3.5M | Sell |
56,194
-2,641,505
| -98% | -$126M | ﹤0.01% | 2211 |
|
|
2019
Q3 | $91.6M | Buy |
2,697,699
+1,234,342
| +84% | +$36.5M | 0.14% | 133 |
|
|
2019
Q2 | $33M | Buy |
1,463,357
+206,868
| +16% | +$4.84M | 0.05% | 516 |
|
|
2019
Q1 | $29.2M | Buy |
1,256,489
+9,849
| +0.8% | +$258K | 0.04% | 580 |
|
|
2018
Q4 | $26.2M | Buy |
1,246,640
+1,163,815
| +1,405% | +$28.6M | 0.04% | 583 |
|
|
2018
Q3 | $3.21M | Buy |
82,825
+55,464
| +203% | +$2.05M | ﹤0.01% | 2107 |
|
|
2018
Q2 | $1.08M | Sell |
27,361
-213,700
| -89% | -$6.29M | ﹤0.01% | 2789 |
|
|
2018
Q1 | $4.83M | Sell |
241,061
-487,522
| -67% | -$12.3M | 0.01% | 1828 |
|
|
2017
Q4 | $16.5M | Buy |
728,583
+40,352
| +6% | +$790K | 0.02% | 1019 |
|
|
2017
Q3 | $13.1M | Buy |
+688,231
| New | +$12.6M | 0.02% | 1065 |
|
Other funds holding DCPH
Millennium Management's DCPH Position: Q2 2024 in Review
Millennium Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 797,100 shares — an estimated $12.5M sold.
Millennium Management first reported a position in DCPH in Q3 2017 and held it in 27 quarters. The position peaked at $91.6M in Q3 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Millennium Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Millennium Management sold 797,100 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $12.5M.
- Millennium Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 27 quarters.
- Millennium Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $91.6M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.